{
    "root": "1baa245b-42c1-448d-9091-179ddff1bff6",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Diflucan",
    "value": "20250325",
    "ingredients": [
        {
            "name": "FLUCONAZOLE",
            "code": "8VZV102JFY",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_46081"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "ANHYDROUS DIBASIC CALCIUM PHOSPHATE",
            "code": "L11K75P92J",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77635"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "ALUMINUM OXIDE",
            "code": "LMI26O6933",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_25741"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17992"
        },
        {
            "name": "TRISODIUM CITRATE DIHYDRATE",
            "code": "B22547B95K"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30769"
        },
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_113455"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_189560"
        }
    ],
    "indications": {
        "text": "diflucan ( fluconazole ) indicated treatment : 1.vaginal candidiasis ( vaginal yeast infections due candida ) . 2.oropharyngeal esophageal candidiasis . open noncomparative relatively small numbers patients , diflucan also effective treatment candida urinary tract infections , peritonitis , systemic candida infections including candidemia , disseminated candidiasis , pneumonia . 3.cryptococcal meningitis . prescribing diflucan ( fluconazole ) aids patients cryptococcal meningitis , please section . comparing diflucan amphotericin b non-hiv infected patients conducted .",
        "doid_entities": [
            {
                "text": "candidiasis (DOID:1508)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1508"
            },
            {
                "text": "esophageal candidiasis (DOID:13146)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13146"
            },
            {
                "text": "peritonitis (DOID:8283)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_8283"
            },
            {
                "text": "pneumonia (DOID:552)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_552"
            },
            {
                "text": "cryptococcal meningitis (DOID:0080159)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0080159"
            },
            {
                "text": "meningitis (DOID:9471)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9471"
            },
            {
                "text": "aids (DOID:635)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_635"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": null,
    "warningsAndPrecautions": "diflucan tablets : pink trapezoidal tablets containing 50 , 100 , 200 mg fluconazole packaged bottles unit dose blisters . 150 mg fluconazole tablets pink oval shaped , packaged single dose unit blister . diflucan tablets supplied follows : diflucan 50 mg tablets : engraved `` diflucan `` `` 50 `` front `` roerig `` back . ndc 0049-3410-30 bottles 30 diflucan 100 mg tablets : engraved `` diflucan `` `` 100 `` front `` roerig `` back . ndc 0049-3420-30 bottles 30 ndc 0049-3420-41 unit dose package 100 diflucan 150 mg tablets : engraved `` diflucan `` `` 150 `` front `` roerig `` back . ndc 0049-3500-79 unit dose package 1 diflucan 200 mg tablets : engraved `` diflucan `` `` 200 `` front `` roerig `` back . ndc 0049-3430-30 bottles 30 ndc 0049-3430-41 unit dose package 100",
    "adverseReactions": "diflucan ( fluconazole ) contraindicated patients shown hypersensitivity fluconazole excipients . information regarding cross-hypersensitivity fluconazole azole antifungal agents . caution used prescribing diflucan patients hypersensitivity azoles . coadministration drugs known prolong qt interval metabolized via enzyme cyp3a4 erythromycin , pimozide , quinidine contraindicated patients receiving fluconazole . ( pharmacology : interaction . )",
    "indications_original": "DIFLUCAN (fluconazole) is indicated for the treatment of:\n                  \n                     \n                        1.Vaginal candidiasis (vaginal yeast infections due to Candida).\n                     \n                        2.Oropharyngeal and esophageal candidiasis. In open noncomparative studies of relatively small numbers of patients, DIFLUCAN was also effective for the treatment of Candida urinary tract infections, peritonitis, and systemic Candida infections including candidemia, disseminated candidiasis, and pneumonia.\n                     \n                        3.Cryptococcal meningitis. Before prescribing DIFLUCAN (fluconazole) for AIDS patients with cryptococcal meningitis, please see \n                           CLINICAL STUDIES\n                         section. Studies comparing DIFLUCAN to amphotericin B in non-HIV infected patients have not been conducted.",
    "warningsAndPrecautions_original": "DIFLUCAN Tablets: Pink trapezoidal tablets containing 50, 100, or 200 mg of fluconazole are packaged in bottles or unit dose blisters. The 150 mg fluconazole tablets are pink and oval shaped, packaged in a single dose unit blister.\n                  DIFLUCAN Tablets are supplied as follows:\n                  DIFLUCAN 50 mg Tablets: Engraved with \"DIFLUCAN\" and \"50\" on the front and \"ROERIG\" on the back.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                           \n                              NDC 0049-3410-30\n                           \n                           \n                              Bottles of 30\n                           \n                        \n                     \n                  \n                  DIFLUCAN 100 mg Tablets: Engraved with \"DIFLUCAN\" and \"100\" on the front and \"ROERIG\" on the back.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                           \n                              NDC 0049-3420-30\n                           \n                           \n                              Bottles of 30\n                           \n                        \n                        \n                           \n                           \n                              NDC 0049-3420-41\n                           \n                           \n                              Unit dose package of 100\n                           \n                        \n                     \n                  \n                  DIFLUCAN 150 mg Tablets: Engraved with \"DIFLUCAN\" and \"150\" on the front and \"ROERIG\" on the back.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                           \n                              NDC 0049-3500-79\n                           \n                           \n                              Unit dose package of 1\n                           \n                        \n                     \n                  \n                  DIFLUCAN 200 mg Tablets: Engraved with \"DIFLUCAN\" and \"200\" on the front and \"ROERIG\" on the back.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                           \n                              NDC 0049-3430-30\n                           \n                           \n                              Bottles of 30\n                           \n                        \n                        \n                           \n                           \n                              NDC 0049-3430-41\n                           \n                           \n                              Unit dose package of 100",
    "adverseReactions_original": "DIFLUCAN (fluconazole) is contraindicated in patients who have shown hypersensitivity to fluconazole or to any of its excipients. There is no information regarding cross-hypersensitivity between fluconazole and other azole antifungal agents. Caution should be used in prescribing DIFLUCAN to patients with hypersensitivity to other azoles. Coadministration of other drugs known to prolong the QT interval and which are metabolized via the enzyme CYP3A4 such as erythromycin, pimozide, and quinidine are contraindicated in patients receiving fluconazole. (See \n                        CLINICAL PHARMACOLOGY: Drug Interaction Studies\n                      and \n                        PRECAUTIONS\n                     .)",
    "drug": [
        {
            "name": "Diflucan",
            "drugbank_id": "https://go.drugbank.com/drugs/DB16138"
        }
    ]
}